Literature DB >> 15256871

Influence of pre-, intra- and post-operative parameters of donor liver on the outcome of isolated human hepatocytes.

E Alexandre1, M Cahn, C Abadie-Viollon, N Meyer, B Heyd, G Mantion, J Cinqualbre, P David, D Jaeck, L Richert.   

Abstract

The aim of the present study was to analyse, retrospectively on a large panel of patients (149), the influence of the donor liver characteristics on the outcome of human hepatocyte isolation obtained from resected liver biopsies from surgical waste after hepatectomy. Among the pre-operative parameters, the type of disease, age and sex of the patient, previous chemotherapy, alcohol or tobacco consumption did not affect the yield, viability, attachment rate and function of the isolated human hepatocytes. Pre-operative biological and anatomopathological data indicated that, while mild steatosis (</=10% steatotic hepatocytes) did also not affect the outcome of hepatocyte isolation, stronger steatosis (>10% steatotic hepatocytes) tended to decrease hepatocyte yield. Cholestasis, as assessed by gamma-glutamyl transferase serum values, significantly negatively correlated with the percentage of digested liver and the yield of viable cells. Intra-operative clamping time, that is, warm ischaemia, longer than 30 min was found to decrease both the percentage of digested liver and cell yield. Among the post-operative parameters, the percentage of digested liver decreased when biopsy weights were higher than 100 g, the use of glue tended to increase both the percentage of digested tissue and the yield of viable cells.In conclusion, human diseased livers appear to be a valuable source of isolated functional human hepatocytes. We recommend, for an optimal isolation, to use liver biopsies weighing less than 100 g, to glue the section surfaces of the biopsies and to avoid the use of moderate steatotic livers (>10% steatotic hepatocytes) and cholestatic livers, as well as livers undergoing warm ischaemia or clamping during resection due to the decrease in cell yield.

Entities:  

Year:  2002        PMID: 15256871     DOI: 10.1023/A:1024614000925

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  12 in total

1.  Isolation of human hepatocytes by a two-step collagenase perfusion procedure.

Authors:  Serene M L Lee; Celine Schelcher; Maresa Demmel; Maria Hauner; Wolfgang E Thasler
Journal:  J Vis Exp       Date:  2013-09-03       Impact factor: 1.355

2.  Hepatocytes isolated from neoplastic liver-immunomagnetic purging as a new source for transplantation.

Authors:  Aravin Gunasegaram; Javed Akhter; Peng Yao; Loreena A Johnson; Stephen M Riodan; David L Morris
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

3.  Clinical Hepatocyte Transplantation: What Is Next?

Authors:  James E Squires; Kyle A Soltys; Patrick McKiernan; Robert H Squires; Stephen C Strom; Ira J Fox; Alejandro Soto-Gutierrez
Journal:  Curr Transplant Rep       Date:  2017-10-14

4.  An algorithm that predicts the viability and the yield of human hepatocytes isolated from remnant liver pieces obtained from liver resections.

Authors:  Serene M L Lee; Celine Schelcher; Rüdiger P Laubender; Natalja Fröse; Reinhard M K Thasler; Tobias S Schiergens; Ulrich Mansmann; Wolfgang E Thasler
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

5.  The isolation of primary hepatocytes from human tissue: optimising the use of small non-encapsulated liver resection surplus.

Authors:  Charlotte J Green; Catriona A Charlton; Lai-Mun Wang; Michael Silva; Karl J Morten; Leanne Hodson
Journal:  Cell Tissue Bank       Date:  2017-07-17       Impact factor: 1.522

6.  Liver tissue fragments obtained from males are the most promising source of human hepatocytes for cell-based therapies - Flow cytometric analysis of albumin expression.

Authors:  Karolina Ewa Zakrzewska; Anna Samluk; Agnieszka Wencel; Krzysztof Dudek; Dorota Genowefa Pijanowska; Krzysztof Dariusz Pluta
Journal:  PLoS One       Date:  2017-08-09       Impact factor: 3.240

7.  Impact of Percoll purification on isolation of primary human hepatocytes.

Authors:  R Horner; J G M V Gassner; M Kluge; P Tang; S Lippert; K H Hillebrandt; S Moosburner; A Reutzel-Selke; J Pratschke; I M Sauer; N Raschzok
Journal:  Sci Rep       Date:  2019-04-25       Impact factor: 4.379

8.  A Simple and Useful Predictive Assay for Evaluating the Quality of Isolated Hepatocytes for Hepatocyte Transplantation.

Authors:  Muneyuki Matsumura; Takehiro Imura; Akiko Inagaki; Hiroyuki Ogasawara; Kengo Fukuoka; Ibrahim Fathi; Shigehito Miyagi; Kazuo Ohashi; Michiaki Unno; Takashi Kamei; Susumu Satomi; Masafumi Goto
Journal:  Sci Rep       Date:  2019-04-16       Impact factor: 4.379

9.  Explanted diseased livers - a possible source of metabolic competent primary human hepatocytes.

Authors:  Moritz Kleine; Marc Riemer; Till Krech; Daphne DeTemple; Mark D Jäger; Frank Lehner; Michael P Manns; Jürgen Klempnauer; Jürgen Borlak; Hueseyin Bektas; Florian W R Vondran
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

10.  Hepatocyte isolation from resected benign tissues: Results of a 5-year experience.

Authors:  Fan-Ying Meng; Li Liu; Jun Liu; Chun-You Li; Jian-Ping Wang; Feng-Hui Yang; Zhi-Shui Chen; Ping Zhou
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.